Mutations in PRKCSH Cause Isolated Autosomal Dominant Polycystic Liver Disease
Open accessThe DOI matches its Crossref record; 40 of the 42 references it cites were found in a registry or an index.
Abstract
Autosomal dominant polycystic liver disease (ADPLD) is a distinct clinical and genetic entity that can occur independently from autosomal dominant polycystic kidney disease (ADPKD). We previously studied two large kindreds and reported localization of a gene for ADPLD to an approximately 8-Mb region, flanked by markers D19S586/D19S583 and D19S593/D19S579, on chromosome 19p13.2-13.1. Expansion of these kindreds and identification of an additional family allowed us to define flanking markers CA267 and CA048 in an approximately 3-Mb region containing >70 candidate genes. We used a combination of denaturing high-performance liquid chromatography (DHPLC) heteroduplex analysis and direct sequencing to screen a panel of 15 unrelated affected individuals for mutations in genes from this interval. We found sequence variations in a known gene, PRKCSH, that were not observed in control individuals, that segregated with the disease haplotype, and that were predicted to be chain-terminating mutations. In contrast to PKD1, PKD2, and PKHD1, PRKCSH encodes a previously described human protein termed "protein kinase C substrate 80K-H" or "noncatalytic beta-subunit of glucosidase II." This protein is highly conserved, is expressed in all tissues tested, and contains a leader sequence, an LDLa domain, two EF-hand domains, and a conserved C-terminal HDEL sequence. Its function may be dependent on calcium binding, and its putative actions include the regulation of N-glycosylation of proteins and signal transduction via fibroblast growth-factor receptor. In light of the focal nature of liver cysts in ADPLD, the apparent loss-of-function mutations in PRKCSH, and the two-hit mechanism operational in dominant polycystic kidney disease, ADPLD may also occur by a two-hit mechanism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, Glucosidase II is involved in human polycystic disease [8,9,10] and finally in the demyelinating ones of the central nervous system (CNS), according to the latest evidence [11].”
From GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review (2022) · cites this paper as [9]
Citations
Cites
Setting the Standards: Quality Control in the Secretory Pathway
Ellgaard, L., Molinari, M., & Helenius, A. (1999) · Science · doi:10.1126/science.286.5446.1882 · Cited by 1,192
Harris, P. C., & Torres, V. E. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.101707.125712 · Cited by 801
Self-citationSomatic Inactivation of Pkd2 Results in Polycystic Kidney Disease
Wu, G., D'Agati, V., Cai, Y., Markowitz, G., Park, J. H., Reynolds, D. M., Maeda, Y., Le, T. C., Hou, H., Kucherlapati, R., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81570-6 · Cited by 570 · cited 2×
“The latter region was excluded from mutation detection, because we hypothesized that—as is the case with ADPKD (Wu et al. 1998)—the liver cystic pathway in ADPLD will be conserved in mice.”
BackgroundSelf-citationRavine, D., Sheffield, L., Danks, D. M., Gibson, R. N., Walker, R. G., & Kincaid-Smith, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92026-5 · Cited by 564 · cited 11×
“The latter region was excluded from mutation detection, because we hypothesized that—as is the case with ADPKD (Wu et al. 1998)—the liver cystic pathway in ADPLD will be conserved in mice.”
BackgroundInfluentialPazour, G. J., San Agustin, J. T., Follit, J. A., Rosenbaum, J. L., & Witman, G. B. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00877-1 · Cited by 531 · cited 2×
“1999) and only selectively trafficked to the primary cilia (Pazour et al. 2002).”
BackgroundOnuchic, L. F., Furu, L., Nagasawa, Y., Hou, X., Eggermann, T., Ren, Z., Bergmann, C., Senderek, J., Esquivel, E., Zeltner, R., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/340448 · Cited by 508 · cited 1×
“A 386-bp RT-PCR product from exons 10–13 of PRKCSH was 32P-labeled using the multiprime method and was hybridized to an adult human MTN blot (Clontech), as described elsewhere (Onuchic et al. 2002).”
MethodSelf-citationNiehues, R., Hasilik, M., Alton, G., Körner, C., Schiebe-Sukumar, M., Koch, H. G., Zimmer, K. P., Wu, R., Harms, E., Reiter, K., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2350 · Cited by 422 · cited 2×
“Interestingly, autosomal recessive carbohydratedeficient glycoprotein syndrome type Ib is associated with congenital hepatic fibrosis and results from nearly complete absence of phosphomannose isomerase, the enzyme needed to maintain the dolichol pyrophosphateoligosaccharide pool (Jaeken et al. 1998; Niehues et al. 19…”
BackgroundThornalley, P. J. (1998) · PubMed · Cited by 387
Identification and Characterization of Polycystin-2, thePKD2 Gene Product
Cai, Y., Maeda, Y., Cedzich, A., Torres, V. E., Wu, G., Hayashi, T., Mochizuki, T., Park, J. H., Witzgall, R., & Somlo, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.40.28557 · Cited by 364 · cited 1×
“It has been suggested that the polycystin-1/2 complex forms in the ER (Newby et al. 2002) and polycystin-2 is largely retained in the ER membrane (Cai et al. 1999) and only selectively trafficked to the primary cilia (Pazour et al. 2002).”
BackgroundSelf-citationLi, Y. M., Mitsuhashi, T., Wojciechowicz, D., Shimizu, N., Li, J., Stitt, A., He, C., Banerjee, D., & Vlassara, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.11047 · Cited by 341 · cited 2×
“Although 80K-H turned out to be a poor substrate for PKC, other possible functions were later suggested by its ability to bind advanced glycation end products (Li et al. 1996; Thornalley 1998) and by its rapid phosphorylation following activation of fibroblast growth-factor receptors (Shaoul et al.”
BackgroundTrombetta, E. S., Simons, J. F., & Helenius, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27509 · Cited by 267 · cited 3×
“This motif constitutes an endoplasmic reticulum (ER) luminal retention sequence (Trombetta et al. 1996; Arendt and Ostergaard 2000), and its loss presumably would result in failure to retain 80K-H/GIIb in the ER.”
BackgroundClinical profile of autosomal dominant polycystic liver disease
Qian, Q., Li, A., King, B. F., Kamath, P. S., Lager, D. J., Huston, J., Shub, C., Davila, S., Somlo, S., & Torres, V. E. (2003) · Hepatology · doi:10.1053/jhep.2003.50006 · Cited by 236
Self-citationWatnick, T. J., Torres, V. E., Gandolph, M. A., Qian, F., Onuchic, L. F., Klinger, K. W., Landes, G., & Germino, G. G. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80135-5 · Cited by 215 · cited 1×
“Liver and kidney cyst formation can occur by a two-hit somatic mutation mechanism resulting in homozygous inactivation of PKD1 or PKD2 at the cellular level (Watnick et al. 1998; Wu et al. 1998).”
BackgroundSelf-citationNewby, L. J., Streets, A. J., Zhao, Y., Harris, P. C., Ward, C. J., & Ong, A. C. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107788200 · Cited by 204 · cited 2×
“It has been suggested that the polycystin-1/2 complex forms in the ER (Newby et al. 2002) and polycystin-2 is largely retained in the ER membrane (Cai et al. 1999) and only selectively trafficked to the primary cilia (Pazour et al. 2002).”
BackgroundLiver resection and cyst fenestration in the treatment of severe polycystic liver disease
Que, F., Nagorney, D. M., Gross, J. B., & Torres, V. E. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90078-0 · Cited by 183 · cited 1×
“Determining factors regarding therapy include the extent, distribution, and anatomy of the cysts, as well as the nature and severity of the symptoms (Que et al. 1995).”
BackgroundSelf-citationJaeken, J., Matthijs, G., Saudubray, J.-M., Dionisi-Vici, C., Bertini, E., de Lonlay, P., Henri, H., Carchon, H., Schollen, E., & Van Schaftingen, E. (1998) · The American Journal of Human Genetics · doi:10.1086/301873 · Cited by 177
Signal Transduction Pathway of Human Fibroblast Growth Factor Receptor 3
Kanai, M., Göke, M., Tsunekawa, S., & Podolsky, D. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6621 · Cited by 137 · cited 1×
“…for PKC, other possible functions were later suggested by its ability to bind advanced glycation end products (Li et al. 1996; Thornalley 1998) and by its rapid phosphorylation following activation of fibroblast growth-factor receptors (Shaoul et al. 1995; Goh et al. 1996; Kanai et al. 1997).”
BackgroundFibroblast growth factor receptors display both common and distinct signaling pathways.
Shaoul, E., Reich‐Slotky, R., Berman, B., & Ron, D. (1995) · PubMed · Cited by 124
Kida, T., Nakanuma, Y., & Terada, T. (1992) · Hepatology · doi:10.1002/hep.1840160209 · Cited by 108 · cited 1×
“Some cysts in polycystic liver disease derive by cystic dilatation of the peribiliary glands that surround and communicate with the large intrahepatic bile ducts (Kida et al. 1992; Qian et al. 2003).”
BackgroundPolycystic liver; analysis of seventy cases.
Pj, M. (1955) · PubMed · Cited by 106
Reynolds, D. M., Falk, C. T., Li, A., King, B. F., Kamath, P. S., Huston, J., Shub, C., Iglesias, D. M., Martín, R. S., Pirson, Y., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/316904 · Cited by 101 · cited 8×
“The mutation in family 1 (Reynolds et al. 2000) results in deletion of the 5′ splice site in IVS16.”
BackgroundInfluentialSelf-citationHepatic venous outflow obstruction in autosomal dominant polycystic kidney disease.
Torres, V. E., Rastogi, S., King, B. F., Stanson, A. W., Gross, J. B., & Nogorney, D. M. (1994) · Journal of the American Society of Nephrology · doi:10.1681/asn.v551186 · Cited by 100
Self-citationGenetic Evidence for the Heterodimeric Structure of Glucosidase II
D'Alessio, C., Fernández, F., Trombetta, E. S., & Parodi, A. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25899 · Cited by 95 · cited 2×
“Cleavage of the terminal glucose by glucosidase I and of the middle glucose by glucosidase II generates a monoglucosylated product (Ellgaard et al. 1999).”
BackgroundPolycystic Disease of the Liver: A Study of 24 Cases
Comfort, M. W., Gray, H. K., Dahlin, D. C., & Whitesell, F. B. (1952) · Gastroenterology · doi:10.1016/s0016-5085(52)80213-6 · Cited by 94
Polycystic kidney disease. 1: Identification and analysis of the primary defect.
Harris, P. C., Ward, C. J., Peral, B., & Hughes, J. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v641125 · Cited by 91
Disorders in protein glycosylation and potential therapy: Tip of an iceberg?
Freeze, H. H. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70096-4 · Cited by 85
Adult polycystic liver and kidney diseases are separate entities
Karhunen, P., & Tenhu, M. (1986) · Clinical Genetics · doi:10.1111/j.1399-0004.1986.tb00565.x · Cited by 85 · cited 11×
“The latter region was excluded from mutation detection, because we hypothesized that—as is the case with ADPKD (Wu et al. 1998)—the liver cystic pathway in ADPLD will be conserved in mice.”
BackgroundInfluentialPirson, Y., Lannoy, N., Peters, D., Geubel, A., Gigot, J., Breuning, M., & Verellen-Dumoulin, C. (1996) · Hepatology · doi:10.1002/hep.510230208 · Cited by 83 · cited 1×
“0002-9297/2003/7203-0019$15.00 (Somlo et al. 1995; Pirson et al. 1996; Iglesias et al. 1999).”
InfluentialWestphal, V., Kjærgaard, S., Davis, J. A., Peterson, S. M., Skovby, F., & Freeze, H. H. (2001) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2001.3161 · Cited by 81 · cited 2×
“Interestingly, autosomal recessive carbohydratedeficient glycoprotein syndrome type Ib is associated with congenital hepatic fibrosis and results from nearly complete absence of phosphomannose isomerase, the enzyme needed to maintain the dolichol pyrophosphateoligosaccharide pool (Jaeken et al. 1998; Niehues et al. 19…”
BackgroundQuaternary and Domain Structure of Glycoprotein Processing Glucosidase II
Trombetta, E. S., Fleming, K. G., & Helenius, A. (2001) · Biochemistry · doi:10.1021/bi010629u · Cited by 80 · cited 3×
“80K-H/GIIb is an alternatively spliced protein that migrates as a doublet at ∼80 kDa on polyacrylamide gels (Arendt and Ostergaard 2000; Trombetta et al. 2001).”
BackgroundThe liver in autosomal dominant polycystic kidney disease. Implications for pathogenesis.
Ramos, A., Torres, V. E., Holley, K. E., Kp, O., Rakela, J. L., & Ludwig, J. (1990) · PubMed · Cited by 78
Self-citationGoh, K. C., Lim, Y. P., Ong, S. H., Siak, C. B., Cao, X., Tan, Y. H., & Guy, G. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5832 · Cited by 67 · cited 1×
“…for PKC, other possible functions were later suggested by its ability to bind advanced glycation end products (Li et al. 1996; Thornalley 1998) and by its rapid phosphorylation following activation of fibroblast growth-factor receptors (Shaoul et al. 1995; Goh et al. 1996; Kanai et al. 1997).”
BackgroundTreml, K., Meimaroglou, D., Hentges, A., & Bause, E. (2000) · Glycobiology · doi:10.1093/glycob/10.5.493 · Cited by 63 · cited 1×
“GIIb does not have enzymatic activity, but it is essential for the maturation of GIIa and its retention in the endoplasmic reticulum (D’Alessio et al. 1999; Treml et al. 2000).”
BackgroundArendt, C. W., & Ostergaard, H. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.13117 · Cited by 55 · cited 1×
“More recently, homologous proteins were identified as the beta subunit of glucosidase II (GIIb) (Trombetta et al. 1996; Arendt and Ostergaard 1997) and as a vacuolar system-associated protein-60 (VASAP-60) (Brule et al. 2000).”
BackgroundHirai, M., & Shimizu, N. (1990) · Biochemical Journal · doi:10.1042/bj2700583 · Cited by 54
Bellefroid, E. J., Marine, J. C., Matera, A. G., Bourguignon, C., Desai, T., Healy, K. C., Bray-Ward, P., Martial, J. A., Ihle, J. N., & Ward, D. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10757 · Cited by 41
Isolated Polycystic Liver Disease Not Linked to Polycystic Kidney Disease 1 and 2
Iglesias, D. M., Palmitano, J. A., Arrizurieta, E., Kornblihtt, A. R., Piñero, M. H., Bernath, V., & Martín, R. S. (1999) · Digestive Diseases and Sciences · doi:10.1023/a:1026623005401 · Cited by 35
Two distinct domains of the -subunit of glucosidase II interact with the catalytic -subunit
Arendt, C., & Ostergaard, H. L. (2000) · Glycobiology · doi:10.1093/glycob/10.5.487 · Cited by 34 · cited 14×
“72:691–703, 2003 and no membrane spans suggesting that without retention by HDEL-mediated binding to the KDEL receptor, it would enter the secretory pathway and be trafficked out of the cell (Arendt and Ostergaard 2000).”
BackgroundInfluentialBrûlé, S., Rabahi, F., Faure, R. L., Beckers, J., Silversides, D. W., & Lussier, J. G. (2000) · Biology of Reproduction · doi:10.1095/biolreprod62.3.642 · Cited by 26 · cited 1×
“More recently, homologous proteins were identified as the beta subunit of glucosidase II (GIIb) (Trombetta et al. 1996; Arendt and Ostergaard 1997) and as a vacuolar system-associated protein-60 (VASAP-60) (Brule et al. 2000).”
BackgroundTorres, V. E. (2015) · Contributions to nephrology · doi:10.1159/000424395 · Cited by 26
Self-citation
Cited by
Roles of N-Linked Glycans in the Endoplasmic Reticulum
Helenius, A., & Aebi, M. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073752 · Cited by 2,037
Autosomal dominant polycystic kidney disease
Torres, V. E., Harris, P. C., & Pirson, Y. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60601-1 · Cited by 1,550
Self-citationBergmann, C., Guay-Woodford, L. M., Harris, P. C., Horie, S., Peters, D. J. M., & Torres, V. E. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0047-y · Cited by 807
Self-citationPorath, B., Gainullin, V. G., Cornec-Le Gall, E., Dillinger, E. K., Heyer, C. M., Hopp, K., Edwards, M. E., Madsen, C. D., Mauritz, S. R., Banks, C. J., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.05.004 · Cited by 475
Self-citationGenetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases
Cornec-Le Gall, E., Torres, V. E., & Harris, P. C. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017050483 · Cited by 406
Self-citation
Metadata
- Authors
- Li, A., Davila, S., Furu, L., Qian, Q., Tian, X., Kamath, P. S., King, B. F., Torres, V. E., & Somlo, S.
- Affiliations
- Yale University (US)
- Mayo Clinic (US)
- Corresponding author
- Somlo, Stefan
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2003-03
- Volume
- 72
- Issue
- 3
- Pages
- 691-703
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC1180260
- OpenAlex
- W2111226757
- Cited by
- 193
- References
- 42
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 7 · 2022: 10 · 2021: 8 · 2020: 8 · 2019: 9 · 2018: 8 · 2017: 7 · 2016: 3 · 2015: 10 · 2014: 13 · 2013: 6 · 2012: 10
- FWCI
- 7.07
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 3793 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (P50DK057328, T32-DK07356, R01DK051041, P50DK57328, DK51041, T32DK007356)
- National Center for Research Resources (M01-RR00 585, M01RR000585)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Keywords
- autosomal dominant polycystic liver disease, PRKCSH, loss-of-function mutations, two-hit mechanism, haplotype mapping, N-glycosylation, fibroblast growth factor receptor signaling, autosomal dominant polycystic kidney disease
- MeSH terms
- Myristoylated Alanine-Rich C Kinase Substrate, Amino Acid Sequence, Base Sequence, Calcium-Binding Proteins, Chromosome Mapping, Chromosomes, Human, Pair 19, Cysts, DNA, Female, Genes, Dominant, Genetic Markers, Glucosidases, Haplotypes, Humans, Genetic Linkage, Liver Diseases, Male, Membrane Proteins, Molecular Sequence Data, Mutation, Pedigree, Phosphoproteins, Protein Kinase C, Sequence Alignment, Polycystic Kidney, Autosomal Dominant, Point Mutation, Sequence Homology, Amino Acid, Alternative Splicing, Amino Acid Substitution, Reverse Transcriptase Polymerase Chain Reaction, Intracellular Signaling Peptides and Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.